They can guide you on dosing, timing, and whether this medication is right for your specific needs
Myth #5: GLP-1 agonists are unsafe with numerous side effects Concerns about the safety of GLP-1 agonists and their potential side effects are common, leading some people to avoid these treatments altogether
Minnesota residents diagnosed with chronic pain, severe muscle spasms, or other qualifying conditions approved by the Minnesota Department of Health may be eligible for certification
Use it every time until you are confident in your measurements
Some might ask for written proof, like a doctors note or detailed prescription information
NICE recommends GLP-1 therapies for adults with BMI 35 kg/m or BMI 3034.9 kg/m with weight-related comorbidities, limited to 2 years' treatment